279 related articles for article (PubMed ID: 29797597)
1. Synthesis, evaluation, and molecular docking studies of aryl urea-triazole-based derivatives as anti-urease agents.
Moghimi S; Goli-Garmroodi F; Allahyari-Devin M; Pilali H; Hassanzadeh M; Mahernia S; Mahdavi M; Firoozpour L; Amanlou M; Foroumadi A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800005. PubMed ID: 29797597
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B
Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Evaluation and Molecular Docking of Deferasirox and Substituted 1,2,4-Triazole Derivatives as Novel Potent Urease Inhibitors: Proposing Repositioning Candidate.
Salehi Ashani R; Azizian H; Sadeghi Alavijeh N; Fathi Vavsari V; Mahernia S; Sheysi N; Biglar M; Amanlou M; Balalaie S
Chem Biodivers; 2020 May; 17(5):e1900710. PubMed ID: 32187446
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro urease inhibitory activity, and molecular docking studies of thiourea and urea derivatives.
Bano B; Kanwal ; Khan KM; Lodhi A; Salar U; Begum F; Ali M; Taha M; Perveen S
Bioorg Chem; 2018 Oct; 80():129-144. PubMed ID: 29913313
[TBL] [Abstract][Full Text] [Related]
5. Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors.
Menteşe E; Emirik M; Sökmen BB
Bioorg Chem; 2019 May; 86():151-158. PubMed ID: 30710848
[TBL] [Abstract][Full Text] [Related]
6. New 1,2,3-triazole-(thio)barbituric acid hybrids as urease inhibitors: Design, synthesis, in vitro urease inhibition, docking study, and molecular dynamic simulation.
Asgari MS; Azizian H; Nazari Montazer M; Mohammadi-Khanaposhtani M; Asadi M; Sepehri S; Ranjbar PR; Rahimi R; Biglar M; Larijani B; Amanlou M; Mahdavi M
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000023. PubMed ID: 32596826
[TBL] [Abstract][Full Text] [Related]
7. Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies.
Kanwal ; Khan M; Arshia ; Khan KM; Parveen S; Shaikh M; Fatima N; Choudhary MI
Bioorg Chem; 2019 Mar; 83():595-610. PubMed ID: 30513472
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors.
Menteşe E; Akyüz G; Yılmaz F; Baltaş N; Emirik M
Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800182. PubMed ID: 30375666
[TBL] [Abstract][Full Text] [Related]
9. An expedient synthesis of N-(1-(5-mercapto-4-((substituted benzylidene)amino)-4H-1,2,4-triazol-3-yl)-2-phenylethyl)benzamides as jack bean urease inhibitors and free radical scavengers: Kinetic mechanism and molecular docking studies.
Saeed A; Larik FA; Channar PA; Mehfooz H; Ashraf MH; Abbas Q; Hassan M; Seo SY
Chem Biol Drug Des; 2017 Nov; 90(5):764-777. PubMed ID: 28388008
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, molecular docking studies and in vitro screening of ethyl 4-(3-benzoylthioureido) benzoates as urease inhibitors.
Saeed A; Khan MS; Rafique H; Shahid M; Iqbal J
Bioorg Chem; 2014 Feb; 52():1-7. PubMed ID: 24269986
[TBL] [Abstract][Full Text] [Related]
11. 1-[(4'-Chlorophenyl) carbonyl-4-(aryl) thiosemicarbazide derivatives as potent urease inhibitors: Synthesis, in vitro and in silico studies.
Ali B; Khan KM; Salar U; Kanwal ; Hussain S; Ashraf M; Riaz M; Wadood A; Taha M; Perveen S
Bioorg Chem; 2018 Sep; 79():363-371. PubMed ID: 29859384
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li X; Li J
Eur J Med Chem; 2017 Jan; 125():423-429. PubMed ID: 27689725
[TBL] [Abstract][Full Text] [Related]
13. Symmetrical Heterocyclic Cage Skeleton: Synthesis, Urease Inhibition Activity, Kinetic Mechanistic Insight, and Molecular Docking Analyses.
Hanif M; Kanwal F; Rafiq M; Hassan M; Mustaqeem M; Seo SY; Zhang Y; Lu C; Chen T; Saleem M
Molecules; 2019 Jan; 24(2):. PubMed ID: 30654516
[TBL] [Abstract][Full Text] [Related]
14. Hybrid benzothiazole analogs as antiurease agent: Synthesis and molecular docking studies.
Taha M; Ismail NH; Imran S; Wadood A; Rahim F; Khan KM; Riaz M
Bioorg Chem; 2016 Jun; 66():80-7. PubMed ID: 27038849
[TBL] [Abstract][Full Text] [Related]
15. 4-Aminocoumarin based Aroylthioureas as Potential Jack Bean Urease Inhibitors; Synthesis, Enzyme Inhibitory Kinetics and Docking Studies.
Fattah TA; Saeed A; Ashraf Z; Abbas Q; Channar PA; Larik FA; Hassan M
Med Chem; 2020; 16(2):229-243. PubMed ID: 31309895
[TBL] [Abstract][Full Text] [Related]
16. 4-Oxycoumarinyl linked acetohydrazide Schiff bases as potent urease inhibitors.
Naz F; Kanwal ; Latif M; Salar U; Khan KM; Al-Rashida M; Ali I; Ali B; Taha M; Perveen S
Bioorg Chem; 2020 Dec; 105():104365. PubMed ID: 33091669
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole-Tetrahydropyrimidinone(thione) Hybrid Scaffolds as Urease Inhibitors.
Rezvanpoor S; Shakour N; Ahangarzadeh N; Bakherad H; Sepehri S; Farhadi G; Hosein Pakdel M; Iranshahi M
Chem Biodivers; 2023 May; 20(5):e202300054. PubMed ID: 37026445
[TBL] [Abstract][Full Text] [Related]
18. 2-(Hetero(aryl)methylene)hydrazine-1-carbothioamides as potent urease inhibitors.
Saeed A; Imran A; Channar PA; Shahid M; Mahmood W; Iqbal J
Chem Biol Drug Des; 2015 Feb; 85(2):225-30. PubMed ID: 24938644
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and molecular docking study of piperazine derivatives as potent urease inhibitors.
Taha M; Wadood A
Bioorg Chem; 2018 Aug; 78():411-417. PubMed ID: 29689419
[TBL] [Abstract][Full Text] [Related]
20. Developing a scaffold for urease inhibition based on benzothiazoles: Synthesis, docking analysis, and therapeutic potential.
Özil M; Tuzcuoğlu Ö; Emirik M; Baltaş N
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100200. PubMed ID: 34545964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
